Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape
Sarah Mcnamee, Neşe Devenot, Meaghan Buisson
JAMA Psychiatry March 29, 2023 DOI: 10.1001/jamapsychiatry.2023.0099 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Citations | 167 |
| Key points | Serious adverse events in psychedelic-assisted therapy trials can be linked to therapist-patient interactions. |
Abstract
This Viewpoint discusses serious adverse events linked to interactions between therapists and patients in trials of psychedelic-assisted therapy.